These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1282 related articles for article (PubMed ID: 3011558)

  • 1. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
    Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
    Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
    Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
    J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture.
    Casslén B; Andersson A; Nilsson IM; Astedt B
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):419-24. PubMed ID: 3090554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
    Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat testicular peritubular cells in culture secrete an inhibitor of plasminogen activator activity.
    Hettle JA; Balekjian E; Tung PS; Fritz IB
    Biol Reprod; 1988 Mar; 38(2):359-71. PubMed ID: 2833945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
    Busso N; Belin D; Failly-Crépin C; Vassalli JD
    Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator in psoriatic scales is of the tissue-type PA as identified by monoclonal antibodies.
    Grøndahl-Hansen J; Nielsen LS; Kristensen P; Grøndahl-Hansen V; Andreasen PA; Danø K
    Br J Dermatol; 1985 Sep; 113(3):257-63. PubMed ID: 3933538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.
    Wagner OF; Vetterlein M; Binder BR
    J Biol Chem; 1986 Nov; 261(31):14474-81. PubMed ID: 3490474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cells.
    Booyse FM; Scheinbuks J; Lin PH; Traylor M; Bruce R
    J Biol Chem; 1988 Oct; 263(29):15129-38. PubMed ID: 3139666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of proteases type plasminogen activator and their inhibitor in cornea.
    Mirshahi M; Mirshahi S; Soria C; Soria J; Thomaidis A; Pouliquen Y; Faure JP
    Biochem Biophys Res Commun; 1989 May; 160(3):1021-5. PubMed ID: 2499321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.
    Nielsen LS; Kellerman GM; Behrendt N; Picone R; Danø K; Blasi F
    J Biol Chem; 1988 Feb; 263(5):2358-63. PubMed ID: 2828365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y; Okada M; Noro A; Matsuda M
    J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
    Hajjar KA; Hamel NM
    J Biol Chem; 1990 Feb; 265(5):2908-16. PubMed ID: 2154465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.
    Nielsen LS; Hansen JG; Skriver L; Wilson EL; Kaltoft K; Zeuthen J; Danø K
    Biochemistry; 1982 Dec; 21(25):6410-5. PubMed ID: 6891264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
    Medcalf RL; Van den Berg E; Schleuning WD
    J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.